Seelos Therapeutics, Inc.
SEELQ
$0.0005
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 105.04% | 62.84% | 48.48% | 37.80% | -10.69% |
| Total Depreciation and Amortization | -27.16% | -13.43% | 7.55% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -199.84% | -152.72% | -83.57% | -73.65% | 87.06% |
| Change in Net Operating Assets | 21.98% | 179.63% | 346.25% | 433.63% | 214.68% |
| Cash from Operations | 67.16% | 66.84% | 61.18% | 47.51% | 39.03% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.02% | -141.62% | -304.71% | -- | -8,050.72% |
| Issuance of Common Stock | 12.09% | 4.26% | 3,483.51% | -24.37% | -41.97% |
| Repurchase of Common Stock | 100.00% | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -16.67% |
| Cash from Financing | 54.25% | -35.07% | 812.27% | -65.11% | -75.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.33% | 71.63% | 80.16% | 39.71% | 22.94% |